0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Comparative sequence analysis of vitamin K‐dependent coagulation factors

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Prothrombin, protein C, and factors VII, IX, and X are vitamin K (VK)‐dependent coagulation proteins that play an important role in the initiation, amplification, and subsequent attenuation of the coagulation response. Blood coagulation evolved in the common vertebrate ancestor as a specialization of the complement system and immune response, which in turn bear close evolutionary ties with developmental enzyme cascades. There is currently no comprehensive analysis of the evolutionary changes experienced by these coagulation proteins during the radiation of vertebrates and little is known about conservation of residues that are important for zymogen activation and catalysis.

          Objectives

          To characterize the conservation level of functionally important residues among VK‐dependent coagulation proteins from different vertebrate lineages.

          Methods

          The conservation level of residues important for zymogen activation and catalysis was analyzed in >1600 primary sequences of VK‐dependent proteins.

          Results

          Functionally important residues are most conserved in prothrombin and least conserved in protein C. Some of the most profound functional modifications in protein C occurred in the ancestor of bony fish when the basic residue in the activation site was replaced by an aromatic residue. Furthermore, during the radiation of placental mammals from marsupials, protein C acquired a cysteine‐rich insert that introduced an additional disulfide in the EGF1 domain and evolved a proprotein convertase cleavage site in the activation peptide linker that also became significantly elongated.

          Conclusions

          Sequence variabilities at functionally important residues may lead to interspecies differences in the zymogen activation and catalytic properties of orthologous VK‐dependent proteins.

          Related collections

          Most cited references75

          • Record: found
          • Abstract: found
          • Article: not found

          COBALT: constraint-based alignment tool for multiple protein sequences.

          A tool that simultaneously aligns multiple protein sequences, automatically utilizes information about protein domains, and has a good compromise between speed and accuracy will have practical advantages over current tools. We describe COBALT, a constraint based alignment tool that implements a general framework for multiple alignment of protein sequences. COBALT finds a collection of pairwise constraints derived from database searches, sequence similarity and user input, combines these pairwise constraints, and then incorporates them into a progressive multiple alignment. We show that using constraints derived from the conserved domain database (CDD) and PROSITE protein-motif database improves COBALT's alignment quality. We also show that COBALT has reasonable runtime performance and alignment accuracy comparable to or exceeding that of other tools for a broad range of problems. COBALT is included in the NCBI C++ toolkit. A Linux executable for COBALT, and CDD and PROSITE data used is available at: ftp://ftp.ncbi.nlm.nih.gov/pub/agarwala/cobalt
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Serine protease mechanism and specificity.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The protein C pathway.

              The protein C anticoagulant pathway serves as a major system for controlling thrombosis, limiting inflammatory responses, and potentially decreasing endothelial cell apoptosis in response to inflammatory cytokines and ischemia. The essential components of the pathway involve thrombin, thrombomodulin, the endothelial cell protein C receptor (EPCR), protein C, and protein S. Thrombomodulin binds thrombin, directly inhibiting its clotting and cell activation potential while at the same time augmenting protein C (and thrombin activatable fibrinolysis inhibitor [TAFI]) activation. Furthermore, thrombin bound to thrombomodulin is inactivated by plasma protease inhibitors > 20 times faster than free thrombin, resulting in increased clearance of thrombin from the circulation. The inhibited thrombin rapidly dissociates from thrombomodulin, regenerating the anticoagulant surface. Thrombomodulin also has direct anti-inflammatory activity, minimizing cytokine formation in the endothelium and decreasing leukocyte-endothelial cell adhesion. EPCR augments protein C activation approximately 20-fold in vivo by binding protein C and presenting it to the thrombin-thrombomodulin activation complex. Activated protein C (APC) retains its ability to bind EPCR, and this complex appears to be involved in some of the cellular signaling mechanisms that down-regulate inflammatory cytokine formation (tumor necrosis factor, interleukin-6). Once APC dissociates from EPCR, it binds to protein S on appropriate cell surfaces where it inactivates factors Va and VIIIa, thereby inhibiting further thrombin generation. Clinical studies reveal that deficiencies of protein C lead to microvascular thrombosis (purpura fulminans). During severe sepsis, a combination of protein C consumption, protein S inactivation, and reduction in activity of the activation complex by oxidation, cytokine-mediated down-regulation, and proteolytic release of the activation components sets in motion conditions that would favor an acquired defect in the protein C pathway, which in turn favors microvascular thrombosis, increased leukocyte adhesion, and increased cytokine formation. APC has been shown clinically to protect patients with severe sepsis. Protein C and thrombomodulin are in early stage clinical trials for this disease, and each has distinct potential advantages and disadvantages relative to APC.
                Bookmark

                Author and article information

                Contributors
                enrico@slu.edu
                Journal
                J Thromb Haemost
                J Thromb Haemost
                10.1111/(ISSN)1538-7836
                JTH
                Journal of Thrombosis and Haemostasis
                John Wiley and Sons Inc. (Hoboken )
                1538-7933
                1538-7836
                11 October 2022
                December 2022
                : 20
                : 12 ( doiID: 10.1111/jth.v20.12 )
                : 2837-2849
                Affiliations
                [ 1 ] Edward A. Doisy Department of Biochemistry and Molecular Biology Saint Louis University School of Medicine St. Louis Missouri USA
                Author notes
                [*] [* ] Correspondence

                Enrico Di Cera, Edward A. Doisy Department of Biochemistry and Molecular Biology, Saint Louis University School of Medicine, 1100 S Grand Blvd, St. Louis, MO 63104 USA.

                Email: enrico@ 123456slu.edu

                Author information
                https://orcid.org/0000-0002-2016-5369
                https://orcid.org/0000-0003-2300-4891
                Article
                JTH15897 JTH-2022-00796.R2
                10.1111/jth.15897
                9669250
                36156849
                a05a76f7-d7cd-4f56-b3db-e823461bf5ae
                © 2022 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 22 September 2022
                : 19 July 2022
                : 22 September 2022
                Page count
                Figures: 5, Tables: 3, Pages: 13, Words: 8273
                Funding
                Funded by: National Heart, Lung, and Blood Institute , doi 10.13039/100000050;
                Award ID: HL049413
                Award ID: HL139554
                Award ID: HL147821
                Categories
                Original Article
                HAEMOSTASIS
                Original Articles
                Custom metadata
                2.0
                December 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.3 mode:remove_FC converted:09.01.2023

                Hematology
                blood coagulation,evolution,protein c,prothrombin,vitamin k‐dependent clotting factors

                Comments

                Comment on this article